Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape — Nash D. Rochman | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape
EK
Shared by
Eugene V Koonin
Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape
Dataset
en
Authors
+3 more
NR
Nash D. Rochman
GF
Guilhem Faure
YW
Yuri I. Wolf
Abstract
1 min read
<p>This repository includes:</p> <p> </p> <p>SI Appendix</p> <p>GISAID Acknowledgements</p> <p>An example resfile</p> <p>RosettaScripts .xml files</p> <p>Complex conformations (50 each) for WT/Delta/Gamma/Omicron; antibody (NAb) and receptor (ACE2)</p>
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Dataset
Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape
Nash D. Rochman
,
Guilhem Faure
,
Yuri I. Wolf
,
Peter L. Freddolino
,
Feng Zhang
,
Eugene V Koonin
Dataset
Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape
Nash D. Rochman
,
Guilhem Faure
,
Yuri I. Wolf
,
Peter L. Freddolino
,
Feng Zhang
,
Eugene V Koonin
Dataset
Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape
Nash D. Rochman
,
Guilhem Faure
,
Yuri I. Wolf
,
Peter L. Freddolino
,
Feng Zhang
,
Eugene V Koonin
Dataset
Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape
Nash D. Rochman
,
Guilhem Faure
,
Yuri I. Wolf
,
Peter L. Freddolino
,
Feng Zhang
,
Eugene V Koonin
Preprint
2021
Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape
Nash D. Rochman
,
Guilhem Faure
,
Yuri I. Wolf
,
Peter L. Freddolino
,
Feng Zhang
,
Eugene V Koonin
Discussion(0)
No comments yet. Be the first to comment.